Literature DB >> 2429987

Antibodies to basement membrane protein nidogen in Chagas' disease and American cutaneous leishmaniasis.

J L Avila, M Rojas, G Velazquez-Avila, H von der Mark, R Timpl.   

Abstract

About 50 to 70% of sera from patients with American cutaneous leishmaniasis and chronic Chagas' disease possessed antibodies which reacted in enzyme and radioimmunoassays with nidogen obtained from a tumor basement membrane. The antibodies were of the immunoglobulin M and G classes in acute American cutaneous leishmaniasis but mainly of the immunoglobulin G class in chronic Chagas' disease. Similar antibodies could not be detected in patients suffering from a variety of other infectious or inflammatory diseases when compared with healthy control groups. Inhibition and immunoadsorption studies indicated a close relationship of epitopes recognized by patients' antibodies on nidogen and on another basement membrane protein, laminin. Since rabbit antisera to both proteins do not cross-react, a special nature of the epitopes involved in the reaction with patient sera is suggested. Similar epitopes may exist on various forms of Leishmania or Trypanosoma protozoa.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429987      PMCID: PMC269027          DOI: 10.1128/jcm.24.5.775-778.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  American trypanosomiasis: Chagas' disease.

Authors:  C A Santos-Buch
Journal:  Int Rev Exp Pathol       Date:  1979

2.  Laminin--a glycoprotein from basement membranes.

Authors:  R Timpl; H Rohde; P G Robey; S I Rennard; J M Foidart; G R Martin
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

3.  Chagas' disease; a clinical, epidemiologic, and pathologic study.

Authors:  E DIAS; F S LARANJA; A MIRANDA; G NOBREGA
Journal:  Circulation       Date:  1956-12       Impact factor: 29.690

4.  Trypanosoma cruzi: defined medium for continuous cultivation of virulent parasites.

Authors:  J L Avila; A Bretaña; M A Casanova; A Avila; F Rodríguez
Journal:  Exp Parasitol       Date:  1979-08       Impact factor: 2.011

5.  Chagasic cardiopathy. Demonstration of a serum gamma globulin factor which reacts with endocardium and vascular structures.

Authors:  P M Cossio; C Diez; A Szarfman; E Kreutzer; B Candiolo; R M Arana
Journal:  Circulation       Date:  1974-01       Impact factor: 29.690

Review 6.  Antibodies to collagens and procollagens.

Authors:  R Timpl
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

7.  Circulating immune complexes and anti-IgG antibodies in mucocutaneous leishmaniasis.

Authors:  P Desjeux; F Santoro; D Afchain; M Loyens; A Capron
Journal:  Am J Trop Med Hyg       Date:  1980-03       Impact factor: 2.345

8.  A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers.

Authors:  D T Hart; K Vickerman; G H Coombs
Journal:  Parasitology       Date:  1981-06       Impact factor: 3.234

9.  Reversible acquisition of a host cell surface membrane antigen by Trypanosoma cruzi.

Authors:  Q Chess; A M Acosta; J K Sethi; C A Santos-Buch
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Antibodies to laminin in Chagas' disease.

Authors:  A Szarfman; V P Terranova; S I Rennard; J M Foidart; M de Fatima Lima; J I Scheinman; G R Martin
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more
  7 in total

1.  Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1-3)-galactose epitopes.

Authors:  A Gabrielli; M Candela; A M Ricciatti; M L Caniglia; J Wieslander
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

2.  Antibodies to basement membrane proteins nidogen and laminin in sera from streptococcal-related diseases and juvenile rheumatoid arthritis patients.

Authors:  J L Avila; M Rojas; G Velázquez-Avila; M Rieber
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

3.  Serological activity against galactosyl-alpha(1-3)galactose in sera from patients with several kinetoplastida infections.

Authors:  J L Avila; M Rojas; H Towbin
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

4.  Persistence of elevated levels of galactosyl-alpha(1-3)galactose antibodies in sera from patients cured of visceral leishmaniasis.

Authors:  J L Avila; M Rojas; L García
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

5.  A galactosyl(alpha 1-3)mannose epitope on phospholipids of Leishmania mexicana and L. braziliensis is recognized by trypanosomatid-infected human sera.

Authors:  J L Avila; M Rojas
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

6.  Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1-3)-galactose epitopes.

Authors:  H Towbin; G Rosenfelder; J Wieslander; J L Avila; M Rojas; A Szarfman; K Esser; H Nowack; R Timpl
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

7.  Distribution of nidogen in the murine eye and ocular phenotype of the nidogen-1 knockout mouse.

Authors:  Christian Albrecht May
Journal:  ISRN Ophthalmol       Date:  2012-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.